Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27797705 | 0.85 | EPHX2 (0.38) | SLC6A3SLC6A4CYP2D6MGAMGAA | |
| SCHEMBL8681546 | 0.80 | SLC6A3 (0.37) | SLC6A3SLC6A4 | |
| SCHEMBL31332791 | 0.76 | SLC6A3 (0.42) | SLC6A3SLC6A4 | |
| SCHEMBL9126560 | 0.72 | SLC6A3 (0.31) | SLC6A3 | |
| SCHEMBL397866 | 0.72 | SLC6A3 (0.31) | SLC6A3 | |
| SCHEMBL27564622 | 0.72 | SLC6A3 (0.40) | SLC6A3SLC6A4 | |
| SCHEMBL29635938 | 0.70 | ESR2 (0.43) | SLC6A3SLC6A4CYP2D6EPHX2 | |
| SCHEMBL27864843 | 0.70 | ESR2 (0.43) | SLC6A3SLC6A4CYP2D6EPHX2 | |
| SCHEMBL28032986 | 0.70 | SMN1; SMN2 (0.45) | SLC6A3SLC6A4EPHX2 | |
| SCHEMBL27542078 | 0.69 | SLC6A3 (0.33) | SLC6A3SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | SLC6A3 4858/4885SLC6A4 4774/4885CYP2D6 650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.